Amarpreet Sawhney compensation by year
OCULAR THERAPEUTIX Summary Compensation Table · all 3 fiscal years held| Component | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Salary | $440,922 | $288,802 | $183,821 |
| Bonus | $121,253 | $158,841 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $1,237,017 | $575,159 | $2,144,675 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $741 | $724 | $434 |
| Total | $1,799,933 | $1,023,526 | $2,328,930 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 29, 2020, accession 0001558370-20-004640, and prior-year filings. Open the filing on EDGAR.
How this page was built: the OCULAR THERAPEUTIX, INC filed document, accession 0001558370-20-004640. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 9,796 | — | $5.93 |
| Option | 63,649 | — | $6.56 |
| Option | 154,168 | — | $4.10 |
| Option | 67,710 | — | $5.47 |
Per the Outstanding Equity Awards at Fiscal Year-End table in OCULAR THERAPEUTIX, INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.
OCULAR THERAPEUTIX’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Amarpreet Sawhney · this page | Former Chairman of the Board | $2,328,930 |
| Antony Mattessich | President and Chief Executive Officer | $2,126,146 |
| Patricia Kitchen | Chief Operations Officer | $1,128,114 |
| Daniel Bollag | Former Chief Strategy Officer | $1,040,883 |
| Michael Goldstein | Chief Medical Officer | $1,007,731 |
The full OCULAR THERAPEUTIX compensation record
free company briefThis page is one person within OCULAR THERAPEUTIX's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the OCULAR THERAPEUTIX proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCULAR THERAPEUTIX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.